Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study
Abstract Background Linezolid (LZD) and daptomycin (DAP) are predominantly used to target gram-positive pathogens; however, treatment effectiveness and adverse reactions for periprosthetic joint infections (PJIs) remain unknown. The aim of this study was to compare the effectiveness and adverse reac...
Main Authors: | Masahiro Sawada, Kenichi Oe, Masayuki Hirata, Hiroshi Kawamura, Narumi Ueda, Tomohisa Nakamura, Hirokazu Iida, Takanori Saito |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-019-1375-7 |
Similar Items
-
Treatment of bacteremia by vancomycin-resistant Enterococcus with daptomycin versus linezolid: a systematic review and meta-analyses
by: Caicedo-Ochoa, Edgar Yaset, et al.
Published: (2017-01-01) -
Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01) -
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
by: Aref Shariati, et al.
Published: (2020-04-01) -
The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis
by: Masoud Dadashi, et al.
Published: (2021-09-01) -
Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 Enterococcus faecium and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United States
by: Amy S. Gargis, et al.
Published: (2022-02-01)